Intensity Therapeutics Logo
  • About Us
    • Our Story
    • Team
  • Technology
  • Clinical Development
    • Products
    • Our Clinical Trials
    • For Patients
Home
  • Media
  • Partnerships
  • Contact Us
  • linkedin
  • twitter

Tuning In: Intensity’s immune-based chemo delivery tech attracts backing of British billionaire Jim Mellon

November 2, 2018
Source: November 2, 2018 published on Endpoints.com
+Back to Media
Back to Top
Intensity Therapeutics Logo

© 2019 Intensity Therapeutics.

  • About Us
    • Our Story
    • Team
  • Technology
  • Clinical Development
    • Products
    • Our Clinical Trials
    • For Patients
  • Media
  • Partnerships
  • Contact Us